3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
48
Lung Neoplasms
24
Carcinoma, Hepatocellular
24
Small Cell Lung Carcinoma
16
Urinary Bladder Neoplasms
12
Cholangiocarcinoma
12
Breast Neoplasms
10
Biliary Tract Neoplasms
10
Neoplasms
9
Neoplasm Metastasis
9
Liver Neoplasms
9
Pancreatic Neoplasms
7
Carcinoma
6
Endometrial Neoplasms
5
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Neoplasms by Site
4
Gallbladder Neoplasms
4
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Respiratory Tract Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Adenocarcinoma
3
Thyroid Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Specimen Handling
6
Human Papillomavirus DNA Tests
4
Colposcopy
4
Papillomavirus Vaccines
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Cisplatin
2
Carboplatin
2
toripalimab
1
fludarabine phosphate
1
fludarabine
1
epigallocatechin gallate
1
aldesleukin
1
Transurethral Resection of Prostate
1
Standing Orders
1
Respiratory Function Tests
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Prochlorperazine
1
Positron-Emission Tomography
1
Platinum
1
Ondansetron
1
O(6)-codeine methyl ether
1
Methods
1
Meperidine
1
Magnetic Resonance Imaging
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Papillomavirus Infections
×
durvalumab
×
90 days
×
Clear all
No trials found.